Litcius/Paper detail

Repurposing of Kinase Inhibitors for Treatment of COVID-19

Ellen Weisberg, Alexander Parent, Priscilla L. Yang, Martin Sattler, Qingsong Liu, Qingwang Liu, Jinhua Wang, Chengcheng Meng, Sara J. Buhrlage, Nathanael S. Gray, James D. Griffin

2020Pharmaceutical Research152 citationsDOIOpen Access PDF

Topics & Concepts

Drug repositioningRepurposingPharmacologyMedicineDrugKinasePharmacokineticsDrug discoveryViral life cycleClinical trialPotencyVirusViral replicationImmunologyBioinformaticsBiologyInternal medicineIn vitroCell biologyEcologyBiochemistryQuinazolinone synthesis and applicationsPARP inhibition in cancer therapyCalcium signaling and nucleotide metabolism
Repurposing of Kinase Inhibitors for Treatment of COVID-19 | Litcius